Saturday, June 11, 2016

OTTAWA DOCTORS' MULTIPLE SCLEROSIS TREATMENT

MS is among the most common chronic inflammatory diseases of the central nervous system, affecting an estimated two million people worldwide.  New Canadian research led by two Ottawa doctors and published in The Lancet medical journal on Thursday suggests the high-risk therapy may stop the disease from progressing.
 

No comments:

Post a Comment